MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 50 filers reported holding MEI PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,755,898 | -6.0% | 7,671,024 | 0.0% | 0.00% | – |
| Q4 2022 | $1,868,661 | -37.0% | 7,671,024 | +0.0% | 0.00% | – |
| Q3 2022 | $2,965,000 | -33.3% | 7,668,708 | +4.4% | 0.00% | – |
| Q2 2022 | $4,444,000 | +18.1% | 7,345,739 | +17.6% | 0.00% | – |
| Q1 2022 | $3,763,000 | -75.6% | 6,245,990 | +8.3% | 0.00% | – |
| Q4 2021 | $15,405,000 | +5.4% | 5,769,739 | +9.0% | 0.00% | – |
| Q3 2021 | $14,612,000 | -2.4% | 5,294,478 | +0.8% | 0.00% | – |
| Q2 2021 | $14,973,000 | -18.6% | 5,253,797 | -2.0% | 0.00% | – |
| Q1 2021 | $18,396,000 | +30.0% | 5,362,989 | +0.0% | 0.00% | – |
| Q4 2020 | $14,153,000 | -14.7% | 5,360,682 | +0.8% | 0.00% | -100.0% |
| Q3 2020 | $16,598,000 | -16.4% | 5,319,783 | +10.7% | 0.00% | 0.0% |
| Q2 2020 | $19,854,000 | +170.5% | 4,807,171 | +5.5% | 0.00% | – |
| Q1 2020 | $7,339,000 | -32.6% | 4,558,453 | +3.8% | 0.00% | – |
| Q4 2019 | $10,894,000 | +129.3% | 4,392,795 | +55.4% | 0.00% | – |
| Q3 2019 | $4,750,000 | -33.3% | 2,827,163 | -0.8% | 0.00% | – |
| Q2 2019 | $7,124,000 | -7.3% | 2,849,609 | +13.8% | 0.00% | – |
| Q1 2019 | $7,689,000 | +21.1% | 2,504,623 | +4.1% | 0.00% | – |
| Q4 2018 | $6,349,000 | -37.1% | 2,404,917 | +2.7% | 0.00% | – |
| Q3 2018 | $10,095,000 | +85.9% | 2,342,115 | +70.0% | 0.00% | – |
| Q2 2018 | $5,430,000 | +79.5% | 1,378,082 | -5.7% | 0.00% | – |
| Q1 2018 | $3,025,000 | -1.9% | 1,461,211 | -0.5% | 0.00% | – |
| Q4 2017 | $3,084,000 | -19.2% | 1,468,451 | +3.1% | 0.00% | – |
| Q3 2017 | $3,816,000 | +115.6% | 1,423,975 | +92.3% | 0.00% | – |
| Q2 2017 | $1,770,000 | +65.7% | 740,580 | +12.3% | 0.00% | – |
| Q1 2017 | $1,068,000 | +20.4% | 659,272 | +7.0% | 0.00% | – |
| Q4 2016 | $887,000 | -54.1% | 615,963 | -43.9% | 0.00% | – |
| Q3 2016 | $1,932,000 | +37.0% | 1,097,959 | +5.9% | 0.00% | – |
| Q2 2016 | $1,410,000 | +8.6% | 1,036,977 | +0.7% | 0.00% | – |
| Q1 2016 | $1,298,000 | -18.1% | 1,029,594 | +4.0% | 0.00% | – |
| Q4 2015 | $1,585,000 | +7.1% | 990,401 | +5.1% | 0.00% | – |
| Q3 2015 | $1,480,000 | -4.8% | 942,405 | +3.7% | 0.00% | – |
| Q2 2015 | $1,554,000 | +9.8% | 908,546 | +14.9% | 0.00% | – |
| Q1 2015 | $1,415,000 | -51.8% | 790,921 | +15.0% | 0.00% | – |
| Q4 2014 | $2,937,000 | -14.8% | 687,833 | +37.6% | 0.00% | – |
| Q3 2014 | $3,449,000 | +14.0% | 499,865 | +4.7% | 0.00% | – |
| Q2 2014 | $3,026,000 | -45.3% | 477,301 | -4.0% | 0.00% | – |
| Q1 2014 | $5,534,000 | +45.2% | 497,231 | +4.5% | 0.00% | – |
| Q4 2013 | $3,810,000 | -5.6% | 475,666 | +33.6% | 0.00% | – |
| Q3 2013 | $4,037,000 | +88.7% | 356,007 | +18.7% | 0.00% | – |
| Q2 2013 | $2,139,000 | – | 300,002 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |